Purpose Obesity causes a prothrombotic state and is known as a predisposing factor for thromboembolic events. In this pilot study, we assessed the impact of surgery for obesity and the subsequent weight loss on blood coagulation using traditional coagulation tests and thromboelastography (TEG).
Introduction
Obesity is a known predisposing factor for thromboembolic events [1] [2] [3] [4] . In obese individuals, there is an up to fivefold increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) with increasing body mass index (BMI) [1] . There are many explanations for this elevated risk such as inactivity, altered venous hemodynamics, and chronically elevated intra-abdominal pressure as well as endothelial dysfunction and hypercoagulability related to excess adipose tissue [5, 6] . Hormones and cytokines produced by adipocytes induce a procoagulant and proinflammatory state, both of which may also play a role in thromboembolic events [2, [7] [8] [9] . Furthermore, obesity is associated with lower limb venous diseases, which further predispose patients to DVT [5] . Obese patients may also have other etiologies for impaired venous return from the lower limbs such as chronically raised intra-abdominal pressure, inactivity, and immobility related to osteoarthritis [6] .
Thromboelastography (TEG) provides information about the entire clotting system by measuring the viscoelastic properties of whole blood during the coagulation process. It has been used to diagnose coagulation disorders and to guide blood transfusions during major surgery, trauma, and postpartum hemorrhage [10] [11] [12] [13] . However, it is also capable of detecting hypercoagulative states [14] [15] [16] . In patients undergoing bariatric surgery, TEG has been shown to be hypercoagulative at the time of the operation [4, 17] .
In this observational pilot study, we assessed the impact of surgery for obesity on blood coagulation using traditional laboratory testing and TEG. According to our hypothesis, surgery for obesity and the subsequent weight loss will alter obesityrelated hypercoagulation towards normal blood coagulation. ). There were two (11%) patients with obesity, five (28%) patients with severe obesity, nine (50%) with morbid obesity, and two (11%) with super obesity. Patients received a fixed dose of enoxaparine 40 mg once daily as a thrombosis prophylaxis, beginning after the operation and continuing 10 days postoperatively except for in one patient who was given an elevated dose of 60 mg because the risk of DVT was estimated to be high.
Materials and Methods

Patients Characteristics
Patient characteristics like age, gender, height, weight, ASA risk classification, comorbidities, type of surgery, duration of surgery, and the use of low molecular-weight heparin were recorded. BMI was calculated according to the formula BMI = weight (kg) ÷ (height [m]) 2 before and 6 months after the operation. DVT or PE diagnosed during the study period was recorded, but not screened systematically.
Blood Sampling
Blood samples were taken at three time points; the morning before entering the operation room (T1), on the first postoperative day (T2), and 6 months after the operation (T3). The traditional laboratory tests analyzed were hemoglobin, platelet count, thromboplastin time, international normalized ratio, fibrinogen, and D-dimer. In addition, we determined highsensitivity C-reactive protein (hsCRP), which reflects inflammation [7] [8] [9] . From TEG parameters, we analyzed R (reaction time) and K (kinetics time), which reflect the initiation of coagulation; α (angle), MA (maximum amplitude), and G (clot strength), which reflect the clot formation; and Ly60, which reflects fibrinolysis at 60 min [18] . All blood samples were taken from an antebrachial vein using a normal venipuncture technique.
TEG Analyses
TEG samples were collected into vacutainer tubes containing 3.2% citrate. For quality control, two separate TEG samples were taken and analyzed. The TEG analyses were performed by a single trained study nurse according to the manufacturer's guidelines. Citrated blood samples were stored at room temperature and analyzed within 30 min. The samples were recalcified before analyses. Kaolin was used as an initiator in each test. Two computerized TEG analyzers (TEG® 5000 Thromboelastograph® Hemostasis System, Haemonetics Corporation, Niles, USA) with four separate channels were used. The TEG analyzers were calibrated and tested regularly.
Data Analysis and Statistics
Summary statistics are presented as the mean with standard deviation (SD) or as the median with 25th and 75th percentiles unless otherwise stated. Repeated measures of TEG data were analyzed using linear mixed model (LMM), with patient as a random effect. Covariance pattern (i.e., correlation structure of the repeated measurements) was chosen according to Akaike's information criteria. If the LMM showed a P time < 0.05, then time points were compared pairwise. Mean differences with 95% confidence intervals (CIs) are presented. Two-tailed p values are presented. Analyses were performed using SAS (version 9.4, SAS Institute Inc., Cary, NC, USA).
Results
A total of 54 blood samples were collected from 18 patients. Most patients were ASA II (55%) and female (83%). Hypertension and diabetes mellitus were the most common comorbidities (Table 1 ). All the patients underwent laparoscopic gastric bypass. There were no DVT or PE diagnosed during the follow-up. During the follow-up period, the mean reduction in body weight was 19.5 kg (SD 6.8), and the mean reduction in BMI was 7.1 kg/m 2 (SD 2.6) ( Table 2 ). All patients were still obese or overweight 6 months after the operation. None of the patients were lost during the 6-month follow-up.
Traditional Laboratory Tests
Before the operation, traditional coagulation tests were within the normal range (Table 3) . HsCRP, which was elevated preoperatively in ten patients (55%), increased significantly on the first postoperative day. There was a significant increase in D-dimer from baseline to the first postoperative day. During the follow-up period, both values returned to baseline. Prior to the operation, fibrinogen level was elevated in eight patients (44%), yet the median fibrinogen level was within the normal range. The median fibrinogen concentration increased postoperatively, but the increase was not statistically significant. Subsequently, the median fibrinogen concentration remained elevated 6 months after the operation; however, there was no significant chance comparing to preoperative values ( Fig. 1) . At the follow-up, the fibrinogen level was above the normal value in ten patients (55%).
TEG
The median R, K, α, and LY60 were within the normal ranges [18] during the whole study period (Table 4) . However, the median MA and G were above the normal ranges and remained elevated up to the 6-month follow-up (Fig. 1) .
Discussion
To our knowledge, this is the first study assessing TEG parameters after weight loss following obesity surgery. We observed that the median MA and G, which indicate increased coagulation, remained elevated during the follow-up. Our patients had increased median hsCRP preoperatively, with a further increase on the first postoperative day, followed by a decline to the normal range 6 months after the operation.
Obesity is associated in elevated risks of arterial and venous thrombosis; however, the underlying pathophysiological mechanism in only partly known [19] . Obesity causes prothrombotic changes in the coagulation system by increasing the levels of coagulation factors and decreasing the levels of fibrinolytic proteins [20] . Arterial thromboses, which result in cardiac ischemia or stroke, are usually a consequence of the rupture of an atherosclerotic plaque, while venous thromboses [21] . However, even though metabolic syndrome seems to be related to VTEs, obesity itself predisposes to VTEs, with or without metabolic syndrome [22] . It is well-established that bariatric surgery and the weight loss that follows improve patients' risk factors of cardiovascular events; yet, only a few studies have investigated the impact of bariatric surgery on blood coagulation. Gastric bypass improves patients' hematological profile by normalizing, for example, T-Quick, AT III, fibrinogen, PAI-1 levels, and endogenous thrombin potential (TG) [23] [24] [25] [26] [27] . Gastric bypass has demonstrated a greater impact on blood coagulation than sleeve gastrectomy [28] . However, both procedures improve fibrinolytic balance and normalize hemostatic variables and natural anticoagulants despite of antithrombin levels. In some cases, bariatric surgery may result in vitamin K deficiency and, furthermore, deficiencies in vitamin K-dependent clotting factors. The risk of vitamin K deficiency is greater in malabsorptive procedures, but may occur after restrictive procedures as well [28] . Many of the changes in blood coagulation, like changes in fibrinogen, FVIII, vWF, and PAI-1 after bariatric surgery, are BMI-related [28] . Previous studies have shown improvements in the coagulation profile, even 1 month of the operation. ATIII and fibrinogen levels, for example, may not normalize until 12 months after surgery [23] . However, there is no data on whether this improvement in the coagulation profile reduces the risk of VTEs.
Only a few studies have investigated TEG [3, 4, 17] and ROTEM [29, 30] parameters during bariatric surgery. These methods enable an assessment the viscoelastic properties of blood from the initiation of the coagulation cascade to fibrinolysis. TEG and ROTEM use whole blood to analyze the coagulation profile, whereas traditional coagulation tests are performed on plasma. The disadvantage of using plasma is that it does not take into account interactions between plasma and other blood components in the coagulation process. Furthermore, viscoelastic tests produce more precise information about clot stability and fibrinolysis. In these studies, patients have been shown to be hypercoagulative at the time of the operation as demonstrated by elevated MA and G, which are related to enhanced clot formation [3, 4] . In comparison with patients of normal weight, patients who are morbidly obese also have reduced R and K, referring to enhanced initiation, as well as increased α, suggesting enhanced clot formation. However, R, K, and α vary within the normal range [17] . Earlier studies have also demonstrated a relationship between high fibrinogen levels and elevated G and MA values in TEG analyses of morbidly obese patients [4, 17] . In our study, patients had elevated G and MA values preoperatively, and these values remained elevated until the end of the 6-month followup. Fibrinogen levels were elevated in 45% of patients prior to the operation and in 65% of patients during the follow-up.
Ongoing inflammation is likely to be associated with a hypercoagulative state in patients with obesity [9] and may FU, follow-up; Hb, hemoglobin; hsCRP, high-sensitivity C-reactive protein; INR, international normalized ratio; pct, percentiles; POD, postoperative day; PREOP, preoperative; F, female; M, male a P value according to linear mixed model elevate the risk of VTE and myocardial infarctation (MI) [31] ; yet, the association between inflammation and coagulation is unclear [32] . Previous research showed that hsCRP, which is a marker of inflammation, is elevated in patients who are obese [33] . In another study, hsCRP was normalized 12 months after gastric bypass as well as the traditional coagulation assays [24] . In our patient population, we observed a preoperative elevation of the median hsCRP, with a further increase on the first postoperative day, followed by a decline to the normal range 6 months after the operation. Our results are in agreements with earlier findings. After bariatric surgery, the risk of DVT varies from 0.07 to 2.4% [34] [35] [36] [37] [38] . We observed no DVT or PE complications. Apart from BMI, age, and comorbidities, the type of bariatric procedure as well as the complexity and duration of surgery all have an impact on the risk [34, 35, 38] . In the present study, only two patients were superobese, and all were less than 61 years of age. Nine patients had none or only one comorbidity, and other patients had comorbidities that were well managed. All of our patients underwent a laparoscopic gastric bypass. All procedures were primary operations and the duration of the surgery was less than 100 min. When considering these special risk factors, the total risk of thromboembolic events in our patient population was only moderate, although TEG values were compliant with hypercoagulation.
Taken together, our findings support the idea that obesityrelated proinflammatory activity is reduced following weight loss after surgery for obesity, although in our series patients remained hypercoagulative (elevated MA, G and fibrinogen). One explanation for a sustained hypercoagulative state in our series could be that our patients were still overweight or obese despite a mean decrease in BMI of 7.1 kg/m 2 . Since the duration of the follow-up was only 6 months, we can only speculate whether a longer follow-up period, enabling greater MA maximum amplitude, G clot strength. P time indicates statistical significance for the change over whole study period weight loss, might have resulted in favorable changes in these parameters.
Limitations
Our study has some limitations. The study population of only 18 patients was rather small and the patient population was rather heterogeneous. Since this was an observational pilot study, we did not perform formal sample size calculation. According to the present results to observe normalization of MA value (MA upper normal value of 69 mm) after gastric bypass would have required 214 patients with a 80% power and alpha of 0.05. However, our results showing hypercoagulation with TEG values are in line with changes in fibrinogen levels and also supported by earlier literature. Six months of follow-up may be too early to see changes in coagulation. The patients lost more than 19 kg of their weight, but they were still obese at the end of the follow-up. An alternative would be to examine the data 1 year after surgery.
The repertoire of traditional coagulation tests was concise since we utilized laboratory tests that are commonly available and in clinical use. All our patients received a single dose of enoxaparine before T2 measurements. The anti-factor Xa (anti-fXA) was determined to examine the possible effect of enoxaparine on our results. According to low anti-fXA levels, the changes in hemostatic parameters on the first postoperative day cannot be explained by an enoxaparine effect.
Future Studies
A longer follow-up (12-24 months) is needed to evaluate whether the abnormalities in TEG parameters are normalized after greater weight loss following surgery for obesity.
Conclusions
Measured by TEG, bariatric patients have hemostatic abnormalities indicating hypercoagulation up to the 6-month follow-up period, suggesting an elevated risk for thromboembolic events for at least 6 months after surgery. 
